Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653886 · ClinicalTrials.gov registry record · NA
Palatability (Energy I Pilot)
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01653886: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT01653886 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01653886, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
A pilot study was conducted to develop the study menus that were similar in appearance, aroma, and taste.
Primary Outcome
The aim of the study is to test for differences in palatability rats of four menus that will be administered during the ENERGY I project. During the pilot study, weill will collect palatability ratings for each menu (breakfast, lunch, and dinner) from four different menus that will be served to participants during the main trial. The menus consist of three diets and baseline. that vary in dietary fat and energy density : 1) high fat/high energy density, 2) hgih fat/low energy density, and 3) hig
Interventions
- OTHER Breakfast (1-2 hours, in the morning)
- OTHER Lunch (1-2 Hours, at midday)
- OTHER Dinner (1-2 hours, in the afternoon)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01653886 record still lists
NCT01653886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Breakfast (1-2 hours, in the morning) is the first listed.
NCT01653886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01653886 about?
NCT01653886 is a clinical study titled "Palatability (Energy I Pilot)". A pilot study was conducted to develop the study menus that were similar in appearance, aroma, and taste.
What is the current status of trial NCT01653886?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2010-10. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01653886?
The interventions under investigation include: Breakfast (1-2 hours, in the morning) (OTHER), Lunch (1-2 Hours, at midday) (OTHER), Dinner (1-2 hours, in the afternoon) (OTHER).
Who is sponsoring clinical trial NCT01653886?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01653886's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia